Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
X-ray attenuation via iodine content leverages the high atomic number of iodine to enhance image contrast in X-ray-based imaging modalities like CT scans. Iodinated contrast agents are administered to patients, and the iodine within these agents preferentially absorbs X-rays, highlighting specific tissues or structures. The degree of attenuation is directly related to the iodine concentration, providing a quantitative basis for diagnosis. However, considerations regarding potential adverse effects and limitations at higher X-ray energies are crucial for clinical applications.
Photoelectric absorption of X-rays by iodine atoms, leading to increased attenuation and image contrast.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X-ray Attenuation via Iodine Content.